Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

Background: The prevalence of type 2 diabetes (T2D) in youth is increasing. Treatment options beyond metformin and insulin are needed. The safety, tolerability, pharmacokinetics, and pharmacodynamics of liraglutide once daily in youth (10–17 years old) with T2D were investigated in a randomized, dou...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Klein, David J., Battelino, Tadej, Chatterjee, D.J., Jacobsen, Lisbeth V., Hale, Paula M., Arslanian, Silva
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Mary Ann Liebert, Inc. 2014
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4183917/
https://ncbi.nlm.nih.gov/pubmed/25036533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2013.0366
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak